Skip to main content

Oncology Startups

Updated November 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
313
Total Funding
$1.6B
Avg Funding
$64.2M
Global Reach
4
countries

Top Cities for Oncology

Bath
Toronto
San Francisco
Chellaston
Oakland
San Diego

Recently Funded Companies

Export
Bath, United Kingdom

Revolver Therapeutics develops peptide therapeutics using a screening platform to target transcription factors for cancer treatment.

$764K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Medicenna is a clinical stage, privately held, immuno-oncology company.

$4.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.

$8.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

$10.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Chellaston, United Kingdom

Thalia Therapeutics is a drug reformulation company.

$3.6M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Oakland, United States

xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.

$46.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.

$3.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Piscataway, United States

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

$226.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Spot BioSystems is a bioengineering firm that specializes in extracellular vesicle mediated mRNA therapy

$40.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Woburn, United States

Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.

$7.3M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Boulder, United States

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

$460.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

$345.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

$1.9M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Lund, Sweden

ChemoTech is an innovator in gentle cancer treatment and effective pain management.

$644K raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Göteborg, Sweden

Elicera Therapeutics develops cell and gene therapies for cancer treatment, with a focus on CAR T-cell therapies and oncolytic viruses.

$5.9M raised
May 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Solstice Health is an AI life sciences marketing platform that offers a clinical data retrieval platform for oncology practice.

$21.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Triomics is a generative AI-powered platform that matches patients to clinical trials.

May 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

May 2026

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

$50.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Stamford, United States

OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.

$6.6M raised
May 2026

Founder Contacts

41,000+ verified contacts

Pacific Palisades, United States

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

$87.5M raised
May 2026

Founder Contacts

41,000+ verified contacts

Warren, United States

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

$3.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Pennsylvania Furnace, United States

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

$250.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

$25.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

May 2026

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 313 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.

Average Funding
$64.2M
Total Funding Tracked
$1.6B
Countries Represented
4

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.San Francisco
3 companies$18.0M
2.South San Francisco
2 companies$345.0M
3.Bath
1 companies$764K
4.Toronto
1 companies$4.4M
5.Chellaston
1 companies$3.6M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked